First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 643-643 ◽  
Author(s):  
D. A. Yardley ◽  
F. A. Greco ◽  
L. L. Porter ◽  
H. A. Burris ◽  
C. Phelps ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Research ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Research Network ◽  
Line Treatment ◽  
First Line ◽  
Cancer Research Network ◽  
Weekly Docetaxel ◽  
First Line Treatment

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

2009 ◽  
Vol 9 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Denise A. Yardley ◽  
Howard A. Burris ◽  
F. Anthony Greco ◽  
Cindy P. Farley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
Weekly Docetaxel ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document